221 related articles for article (PubMed ID: 16312384)
1. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
2. Introduction to antifungal drugs.
Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
[No Abstract] [Full Text] [Related]
3. New generation azole antifungals in clinical investigation.
Girmenia C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1279-95. PubMed ID: 19678798
[TBL] [Abstract][Full Text] [Related]
4. [Clinical-microbiological correlation in patients treated with azoles].
Quereda Rodriguez Navarro C
Rev Esp Quimioter; 2004 Mar; 17(1):91-3. PubMed ID: 15201930
[No Abstract] [Full Text] [Related]
5. [Azole derivatives--new drugs in the treatment of mycoses].
Gwieździński Z; Urbanowski S
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):740-4. PubMed ID: 2084630
[No Abstract] [Full Text] [Related]
6. Current approaches and future strategies for the implementation of pharmacogenomics in the clinical use of azole antifungal drugs.
García-García I; Borobia AM
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):509-514. PubMed ID: 33622115
[No Abstract] [Full Text] [Related]
7. Second-generation azole antifungal agents.
Kale P; Johnson LB
Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
[TBL] [Abstract][Full Text] [Related]
8. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
9. Current and emerging azole antifungal agents.
Sheehan DJ; Hitchcock CA; Sibley CM
Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
[TBL] [Abstract][Full Text] [Related]
10. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
Moudgal VV; Sobel JD
Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
[TBL] [Abstract][Full Text] [Related]
11. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
12. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology].
Vazquez Lopez L
Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932
[No Abstract] [Full Text] [Related]
13. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
14. [Azoles: Prophylactic or therapeutic?].
Jarque I
Rev Esp Quimioter; 2004 Mar; 17(1):94-7. PubMed ID: 15201931
[No Abstract] [Full Text] [Related]
15. Antifungal stewardship: towards defining safe stopping criteria for therapeutic oral azoles.
Marzolini MA; Thomson KJ; Peggs KS
Br J Haematol; 2016 Jan; 172(2):285-7. PubMed ID: 25939287
[No Abstract] [Full Text] [Related]
16. Azole antifungal drugs: old and new.
Dismukes WE
Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
[No Abstract] [Full Text] [Related]
17. Antifungal therapy and the new azole compounds.
Hay RJ
J Antimicrob Chemother; 1991 Jul; 28 Suppl A():35-46. PubMed ID: 1938705
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery strategies for improved azole antifungal action.
Yang W; Wiederhold NP; Williams RO
Expert Opin Drug Deliv; 2008 Nov; 5(11):1199-216. PubMed ID: 18976131
[TBL] [Abstract][Full Text] [Related]
19. Basic mechanisms of antifungal chemotherapy.
Drouhet E
Mod Treat; 1970 May; 7(3):539-64. PubMed ID: 4920804
[No Abstract] [Full Text] [Related]
20. Antifungal serum concentration monitoring: an update.
Goodwin ML; Drew RH
J Antimicrob Chemother; 2008 Jan; 61(1):17-25. PubMed ID: 17999982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
